Evidence map›Paper›PMID 42391850›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Microbiome analysis of Cystic Fibrosis sputum presents higher sensitivity than the conventional bacterial culture.

Fabiana Caroline Zempulski Volpato, Otávio von Ameln Lovison, Daiana de Lima-Morales, Evelyn Kern Almeida, Pabulo Henrique Rampelotto, Andreza Francisco Martins, Paulo José Cauduro Maróstica, Afonso Luís Barth

Abstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fabiana Caroline Zempulski VolpatoHospital de Clínicas de Porto Alegre, LABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Porto Alegre, RS, Brazil; Universidade Federal do Paraná, Departamento de Biociências, Palotina, PR, Brazil. Electronic address: fabiana.volpato@ufpr.br.
Otávio von Ameln LovisonHospital de Clínicas de Porto Alegre, LABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Porto Alegre, RS, Brazil; Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Ciências Farmacêuticas, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Bioinformatics Core, Porto Alegre, RS, Brazil.
Daiana de Lima-MoralesHospital de Clínicas de Porto Alegre, LABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Porto Alegre, RS, Brazil.
Evelyn Kern AlmeidaHospital de Clínicas de Porto Alegre, LABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Porto Alegre, RS, Brazil.
Pabulo Henrique RampelottoUniversidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil.
Andreza Francisco MartinsHospital de Clínicas de Porto Alegre, LABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Porto Alegre, RS, Brazil; Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Ciências Farmacêuticas, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Bioinformatics Core, Porto Alegre, RS, Brazil.
Paulo José Cauduro MarósticaUniversidade Federal do Rio Grande do Sul, Programa de Pós-graduação em Saúde da Criança e do Adolescente, Porto Alegre, RS, Brazil.
Afonso Luís BarthHospital de Clínicas de Porto Alegre, LABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Porto Alegre, RS, Brazil; Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Ciências Farmacêuticas, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Bioinformatics Core, Porto Alegre, RS, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicrobiological communities in the airway of Cystic Fibrosis (CF) patients may be associated with clinical conditions and bacterial exacerbation. The main aim of this study was to establish the correlation between the airway microbiome and the bacteriological culture. We also correlated the microbiome data with the CFTR mutation, presence/absence of leukocytes and hospitalization status of CF patients.

aimsTo establish the correlation between the airway microbiome and the bacteriological culture. We also correlated the microbiome data with the CFTR mutation, presence/absence of leukocytes and hospitalization status of patients. METHODS AND

resultsSputum collected for routine bacteriological culture of 27 CF patients was submitted to microbiome sequencing. Library of 16S rRNA was prepared using a V3V4 region. The Amplicon Sequence Variants (ASV) obtained from sequencing were compared according with the CFTR mutation and laboratory parameters. Leukocytes in the sputum were evaluated by a differential slide counting in microscopy. The genus Staphylococcus and Pseudomonas were detected by microbiome analysis in all sputa while Staphylococcus aureus was identified in only 19 (70.4%) and Pseudomonas aeruginosa in only 9 (33.3%) sputa by bacteriological culture. In 14 specimens the genus Burkholderia (Burkholderia-Caballeronia-Paraburkholderia) was detected by microbiome analysis; however, the Burkholderia cepacia complex was identified in only 8 sputa by bacteriological culture. Lower alpha diversity was directly correlated to the leukocyte presence and hospitalized patients. There was no significant difference in alpha diversity and CFTR mutations.

conclusionThe use of NSG resources has become an important tool to improve the knowledge of the microbial profile of a CF patient. Our findings contribute to a better understanding of that the evaluation of the airway microbiome of CF patients plays an important role to better understand the pulmonary microbiota and to anticipate the detection of common CF pathogens.

Indexed as

BacteriaCystic FibrosisMicrobiotaSputumAdolescentAdultChildCystic Fibrosis Transmembrane Conductance RegulatorFemaleHumansMaleMutationRNA, Ribosomal, 16SYoung AdultCystic Fibrosis Transmembrane Conductance RegulatorRNA, Ribosomal, 16SASVCulture-independent techniqueCystic FibrosisLung microbiomeMicrobiological community

Identifiers

PMID42391850
PMCPMC13352373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.